HEADER IMMUNE SYSTEM 03-JUL-08 3DO3 TITLE HUMAN 1GG1 FC FRAGMENT, 2.5 ANGSTROM STRUCTURE COMPND MOL_ID: 1; COMPND 2 MOLECULE: IG GAMMA-1 CHAIN C REGION; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: FC DOMAIN INCLUDING CH2 AND CH3 REGIONS: UNP RESIDUES 119- COMPND 5 330; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 GENE: IGHG1; SOURCE 5 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: MOUSE NSO CELLS KEYWDS IMMUNOGLOBULIN FOLD, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, KEYWDS 2 IMMUNOGLOBULIN DOMAIN, SECRETED, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR B.C.BRADEN REVDAT 4 30-AUG-23 3DO3 1 REMARK HETSYN REVDAT 3 29-JUL-20 3DO3 1 COMPND REMARK SEQADV HETNAM REVDAT 3 2 1 LINK SITE ATOM REVDAT 2 13-JUL-11 3DO3 1 VERSN REVDAT 1 21-JUL-09 3DO3 0 JRNL AUTH B.C.BRADEN JRNL TITL HUMAN 1GG1 FC FRAGMENT, 2.5 ANGSTROM STRUCTURE. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 17.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.0 REMARK 3 NUMBER OF REFLECTIONS : 18761 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.280 REMARK 3 FREE R VALUE : 0.330 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1836 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.52 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 403 REMARK 3 BIN R VALUE (WORKING SET) : 0.4746 REMARK 3 BIN FREE R VALUE : 0.4917 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 43 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3345 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 220 REMARK 3 SOLVENT ATOMS : 99 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.314 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3DO3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-JUL-08. REMARK 100 THE DEPOSITION ID IS D_1000048277. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-NOV-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : CONFOCAL MIRRORS REMARK 200 OPTICS : CONFOCAL MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19709 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.490 REMARK 200 RESOLUTION RANGE LOW (A) : 17.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.02800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.17000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 2HWZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 3350, 0.2M NACL PH 6.4, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.10265 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.37465 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.10785 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 69.37465 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.10265 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.10785 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CHAINS A AND B FORM THE BIOLOGICAL UNIT (FC DOMAIN HEAVY REMARK 300 CHAIN CONTAINS DOMAINS CH3 AND CH4) REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 445 REMARK 465 GLY A 446 REMARK 465 LYS A 447 REMARK 465 GLY B 446 REMARK 465 LYS B 447 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 290 CD CE NZ REMARK 480 LYS A 326 CD CE NZ REMARK 480 ARG A 355 CG CD NE CZ NH1 NH2 REMARK 480 GLN A 418 CG CD OE1 NE2 REMARK 480 GLU B 272 CG CD OE1 OE2 REMARK 480 GLU B 293 CB CG CD OE1 OE2 REMARK 480 GLU B 294 CG CD OE1 OE2 REMARK 480 GLN B 295 CG CD OE1 NE2 REMARK 480 TYR B 300 CG CD1 CD2 CE1 CE2 CZ OH REMARK 480 ARG B 301 CD NE CZ NH1 NH2 REMARK 480 GLU B 356 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 455 O HOH A 484 1.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 ND2 ASN A 389 ND2 ASN B 389 3545 0.91 REMARK 500 CE1 HIS A 268 CE1 HIS A 285 4455 1.02 REMARK 500 ND1 HIS A 268 CE1 HIS A 285 4455 1.12 REMARK 500 ND1 HIS A 268 ND1 HIS A 285 4455 1.13 REMARK 500 CG ASN A 389 ND2 ASN B 389 3545 1.96 REMARK 500 CE1 HIS A 268 NE2 HIS A 285 4455 2.07 REMARK 500 CE1 HIS A 268 ND1 HIS A 285 4455 2.08 REMARK 500 ND2 ASN A 389 CG ASN B 389 3545 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 287 -174.35 -63.68 REMARK 500 ARG A 292 158.39 -35.52 REMARK 500 TYR A 296 -18.77 48.86 REMARK 500 LYS A 326 25.23 -64.19 REMARK 500 ALA A 327 27.57 -149.73 REMARK 500 MET A 358 54.45 -68.34 REMARK 500 THR A 359 -1.53 -145.48 REMARK 500 SER A 403 -167.30 -79.08 REMARK 500 ARG A 416 -58.07 -138.94 REMARK 500 GLN A 419 36.29 -93.47 REMARK 500 GLU B 269 -76.99 -43.12 REMARK 500 ASP B 280 31.86 78.44 REMARK 500 GLU B 283 89.82 51.83 REMARK 500 ASN B 286 -15.53 168.30 REMARK 500 ARG B 292 -172.52 -56.12 REMARK 500 TYR B 296 31.66 33.72 REMARK 500 ASN B 297 41.29 -145.32 REMARK 500 ARG B 301 89.02 -152.98 REMARK 500 ASP B 312 -74.05 -49.25 REMARK 500 SER B 324 -172.27 -64.80 REMARK 500 ASN B 325 157.09 175.05 REMARK 500 ALA B 327 43.02 -149.44 REMARK 500 PRO B 329 -62.35 -9.51 REMARK 500 GLU B 356 20.24 -68.52 REMARK 500 PRO B 374 -169.65 -74.16 REMARK 500 HIS B 435 22.59 49.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2HWZ RELATED DB: PDB REMARK 900 FAB FRAGMENT OF HUMANIZED ANTI-VIRAL ANTIBODY MEDI-493 (SYNAGIS TM) DBREF 3DO3 A 236 447 UNP P01857 IGHG1_HUMAN 119 330 DBREF 3DO3 B 236 447 UNP P01857 IGHG1_HUMAN 119 330 SEQADV 3DO3 GLU A 356 UNP P01857 ASP 239 VARIANT SEQADV 3DO3 MET A 358 UNP P01857 LEU 241 VARIANT SEQADV 3DO3 GLU B 356 UNP P01857 ASP 239 VARIANT SEQADV 3DO3 MET B 358 UNP P01857 LEU 241 VARIANT SEQRES 1 A 212 GLY GLY PRO SER VAL PHE LEU PHE PRO PRO LYS PRO LYS SEQRES 2 A 212 ASP THR LEU MET ILE SER ARG THR PRO GLU VAL THR CYS SEQRES 3 A 212 VAL VAL VAL ASP VAL SER HIS GLU ASP PRO GLU VAL LYS SEQRES 4 A 212 PHE ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN ALA SEQRES 5 A 212 LYS THR LYS PRO ARG GLU GLU GLN TYR ASN SER THR TYR SEQRES 6 A 212 ARG VAL VAL SER VAL LEU THR VAL LEU HIS GLN ASP TRP SEQRES 7 A 212 LEU ASN GLY LYS GLU TYR LYS CYS LYS VAL SER ASN LYS SEQRES 8 A 212 ALA LEU PRO ALA PRO ILE GLU LYS THR ILE SER LYS ALA SEQRES 9 A 212 LYS GLY GLN PRO ARG GLU PRO GLN VAL TYR THR LEU PRO SEQRES 10 A 212 PRO SER ARG GLU GLU MET THR LYS ASN GLN VAL SER LEU SEQRES 11 A 212 THR CYS LEU VAL LYS GLY PHE TYR PRO SER ASP ILE ALA SEQRES 12 A 212 VAL GLU TRP GLU SER ASN GLY GLN PRO GLU ASN ASN TYR SEQRES 13 A 212 LYS THR THR PRO PRO VAL LEU ASP SER ASP GLY SER PHE SEQRES 14 A 212 PHE LEU TYR SER LYS LEU THR VAL ASP LYS SER ARG TRP SEQRES 15 A 212 GLN GLN GLY ASN VAL PHE SER CYS SER VAL MET HIS GLU SEQRES 16 A 212 ALA LEU HIS ASN HIS TYR THR GLN LYS SER LEU SER LEU SEQRES 17 A 212 SER PRO GLY LYS SEQRES 1 B 212 GLY GLY PRO SER VAL PHE LEU PHE PRO PRO LYS PRO LYS SEQRES 2 B 212 ASP THR LEU MET ILE SER ARG THR PRO GLU VAL THR CYS SEQRES 3 B 212 VAL VAL VAL ASP VAL SER HIS GLU ASP PRO GLU VAL LYS SEQRES 4 B 212 PHE ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN ALA SEQRES 5 B 212 LYS THR LYS PRO ARG GLU GLU GLN TYR ASN SER THR TYR SEQRES 6 B 212 ARG VAL VAL SER VAL LEU THR VAL LEU HIS GLN ASP TRP SEQRES 7 B 212 LEU ASN GLY LYS GLU TYR LYS CYS LYS VAL SER ASN LYS SEQRES 8 B 212 ALA LEU PRO ALA PRO ILE GLU LYS THR ILE SER LYS ALA SEQRES 9 B 212 LYS GLY GLN PRO ARG GLU PRO GLN VAL TYR THR LEU PRO SEQRES 10 B 212 PRO SER ARG GLU GLU MET THR LYS ASN GLN VAL SER LEU SEQRES 11 B 212 THR CYS LEU VAL LYS GLY PHE TYR PRO SER ASP ILE ALA SEQRES 12 B 212 VAL GLU TRP GLU SER ASN GLY GLN PRO GLU ASN ASN TYR SEQRES 13 B 212 LYS THR THR PRO PRO VAL LEU ASP SER ASP GLY SER PHE SEQRES 14 B 212 PHE LEU TYR SER LYS LEU THR VAL ASP LYS SER ARG TRP SEQRES 15 B 212 GLN GLN GLY ASN VAL PHE SER CYS SER VAL MET HIS GLU SEQRES 16 B 212 ALA LEU HIS ASN HIS TYR THR GLN LYS SER LEU SER LEU SEQRES 17 B 212 SER PRO GLY LYS MODRES 3DO3 ASN A 297 ASN GLYCOSYLATION SITE MODRES 3DO3 ASN B 297 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET MAN C 4 11 HET NAG C 5 14 HET GAL C 6 11 HET MAN C 7 11 HET NAG C 8 14 HET FUL C 9 10 HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET MAN D 4 11 HET NAG D 5 14 HET GAL D 6 11 HET MAN D 7 11 HET NAG D 8 14 HET FUL D 9 10 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM FUL BETA-L-FUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN FUL BETA-L-FUCOSE; 6-DEOXY-BETA-L-GALACTOPYRANOSE; L- HETSYN 2 FUL FUCOSE; FUCOSE; 6-DEOXY-BETA-L-GALACTOSE FORMUL 3 NAG 8(C8 H15 N O6) FORMUL 3 BMA 2(C6 H12 O6) FORMUL 3 MAN 4(C6 H12 O6) FORMUL 3 GAL 2(C6 H12 O6) FORMUL 3 FUL 2(C6 H12 O5) FORMUL 5 HOH *99(H2 O) HELIX 1 1 LYS A 246 MET A 252 1 7 HELIX 2 2 LEU A 309 ASN A 315 1 7 HELIX 3 3 SER A 354 MET A 358 5 5 HELIX 4 4 ASP A 413 GLN A 418 1 6 HELIX 5 5 LEU A 432 TYR A 436 5 5 HELIX 6 6 LYS B 246 MET B 252 1 7 HELIX 7 7 LEU B 309 ASN B 315 1 7 HELIX 8 8 SER B 354 MET B 358 5 5 HELIX 9 9 LYS B 414 GLN B 419 1 6 HELIX 10 10 LEU B 432 ASN B 434 5 3 SHEET 1 A 4 SER A 239 PHE A 243 0 SHEET 2 A 4 GLU A 258 VAL A 266 -1 O VAL A 262 N PHE A 241 SHEET 3 A 4 TYR A 300 THR A 307 -1 O VAL A 302 N VAL A 263 SHEET 4 A 4 LYS A 288 THR A 289 -1 N LYS A 288 O VAL A 305 SHEET 1 B 4 VAL A 282 VAL A 284 0 SHEET 2 B 4 VAL A 273 VAL A 279 -1 N VAL A 279 O VAL A 282 SHEET 3 B 4 TYR A 319 ASN A 325 -1 O LYS A 322 N ASN A 276 SHEET 4 B 4 ILE A 332 ILE A 336 -1 O ILE A 332 N VAL A 323 SHEET 1 C 4 GLN A 347 LEU A 351 0 SHEET 2 C 4 VAL A 363 PHE A 372 -1 O LEU A 368 N TYR A 349 SHEET 3 C 4 PHE A 404 VAL A 412 -1 O VAL A 412 N VAL A 363 SHEET 4 C 4 TYR A 391 THR A 393 -1 N LYS A 392 O LYS A 409 SHEET 1 D 4 GLN A 347 LEU A 351 0 SHEET 2 D 4 VAL A 363 PHE A 372 -1 O LEU A 368 N TYR A 349 SHEET 3 D 4 PHE A 404 VAL A 412 -1 O VAL A 412 N VAL A 363 SHEET 4 D 4 VAL A 397 LEU A 398 -1 N VAL A 397 O PHE A 405 SHEET 1 E 4 GLN A 386 PRO A 387 0 SHEET 2 E 4 ALA A 378 SER A 383 -1 N SER A 383 O GLN A 386 SHEET 3 E 4 VAL A 422 MET A 428 -1 O SER A 426 N GLU A 380 SHEET 4 E 4 THR A 437 SER A 442 -1 O LEU A 441 N PHE A 423 SHEET 1 F 2 GLU B 258 THR B 260 0 SHEET 2 F 2 VAL B 305 THR B 307 -1 O LEU B 306 N VAL B 259 SHEET 1 G 3 ASN B 276 VAL B 279 0 SHEET 2 G 3 TYR B 319 LYS B 322 -1 O LYS B 320 N TYR B 278 SHEET 3 G 3 THR B 335 ILE B 336 -1 O ILE B 336 N TYR B 319 SHEET 1 H 4 GLN B 347 LEU B 351 0 SHEET 2 H 4 GLN B 362 PHE B 372 -1 O THR B 366 N LEU B 351 SHEET 3 H 4 PHE B 404 ASP B 413 -1 O LEU B 410 N LEU B 365 SHEET 4 H 4 TYR B 391 THR B 393 -1 N LYS B 392 O LYS B 409 SHEET 1 I 4 GLN B 347 LEU B 351 0 SHEET 2 I 4 GLN B 362 PHE B 372 -1 O THR B 366 N LEU B 351 SHEET 3 I 4 PHE B 404 ASP B 413 -1 O LEU B 410 N LEU B 365 SHEET 4 I 4 VAL B 397 LEU B 398 -1 N VAL B 397 O PHE B 405 SHEET 1 J 4 GLN B 386 PRO B 387 0 SHEET 2 J 4 ALA B 378 SER B 383 -1 N SER B 383 O GLN B 386 SHEET 3 J 4 VAL B 422 MET B 428 -1 O SER B 426 N GLU B 380 SHEET 4 J 4 TYR B 436 SER B 442 -1 O LEU B 441 N PHE B 423 SSBOND 1 CYS A 261 CYS A 321 1555 1555 2.03 SSBOND 2 CYS A 367 CYS A 425 1555 1555 2.03 SSBOND 3 CYS B 261 CYS B 321 1555 1555 2.03 SSBOND 4 CYS B 367 CYS B 425 1555 1555 2.02 LINK ND2 ASN A 297 C1 NAG C 1 1555 1555 1.45 LINK ND2 ASN B 297 C1 NAG D 1 1555 1555 1.45 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.39 LINK O6 NAG C 1 C1 FUL C 9 1555 1555 1.39 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.38 LINK O6 BMA C 3 C1 MAN C 4 1555 1555 1.40 LINK O3 BMA C 3 C1 MAN C 7 1555 1555 1.39 LINK O2 MAN C 4 C1 NAG C 5 1555 1555 1.39 LINK O4 NAG C 5 C1 GAL C 6 1555 1555 1.39 LINK O2 MAN C 7 C1 NAG C 8 1555 1555 1.40 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.39 LINK O6 NAG D 1 C1 FUL D 9 1555 1555 1.40 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.39 LINK O6 BMA D 3 C1 MAN D 4 1555 1555 1.40 LINK O3 BMA D 3 C1 MAN D 7 1555 1555 1.39 LINK O2 MAN D 4 C1 NAG D 5 1555 1555 1.39 LINK O4 NAG D 5 C1 GAL D 6 1555 1555 1.39 LINK O2 MAN D 7 C1 NAG D 8 1555 1555 1.39 CISPEP 1 TYR A 373 PRO A 374 0 -0.44 CISPEP 2 TYR B 373 PRO B 374 0 -0.42 CRYST1 50.205 80.216 138.749 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019918 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012466 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007207 0.00000